Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D

Area of Science:

• Hepatology
• Virology
• Genetics

Background:

• Single nucleotide polymorphisms (SNPs) near the interferon lambda-3 (IFNλ3) gene influence hepatitis C treatment response.
• The role of these SNPs in hepatitis D (HDV) treatment outcomes requires investigation.

Purpose of the Study:

• To investigate the influence of the IFNλ3 rs12979860 SNP on treatment response in hepatitis D patients.
• To identify factors associated with virological response and spontaneous clearance in HDV infection.

Main Methods:

• Study included 64 hepatitis D patients treated with pegylated interferon for one year.
• IFNλ3 rs12979860 SNP genotyped using polymerase chain reaction-restriction fragment length polymorphism.
• Patient outcomes assessed for sustained virological response, non-response, relapse, and spontaneous clearance.

Main Results:

• No significant association found between IFNλ3 rs12979860 genotype and sustained virological response or spontaneous clearance.
• Older age (median 33.5 vs 26 years) and presence of cirrhosis were associated with treatment failure (P=0.024 and P=0.003, respectively).
• Cirrhosis was identified as an independent risk factor for treatment failure (P=0.001).

Conclusions:

• The IFNλ3 rs12979860 SNP does not significantly influence long-term hepatitis D clearance.
• Cirrhosis is a significant factor affecting treatment response in hepatitis D patients.
• Further research may explore other genetic or clinical factors influencing HDV clearance.